Rhenman & Partners Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-88,600
Closed -$13M 97
2019
Q1
$13M Sell
88,600
-10,000
-10% -$1.45M 1.52% 24
2018
Q4
$13.2M Buy
98,600
+28,555
+41% +$4.68M 1.51% 33
2018
Q3
$13.3M Sell
70,045
-55,000
-44% -$10.1M 1.34% 35
2018
Q2
$20.8M Buy
125,045
+65,045
+108% +$10.4M 2.13% 17
2018
Q1
$10.1M Buy
60,000
+948
+2% +$159K 1.24% 34
2017
Q4
$9.66M Sell
59,052
-40,948
-41% -$7.35M 1.31% 28
2017
Q3
$20.5M Buy
100,000
+48,000
+92% +$11.2M 2.62% 9
2017
Q2
$12.6M Sell
52,000
-7,000
-12% -$1.64M 1.82% 19
2017
Q1
$14.1M Sell
59,000
-17,000
-22% -$3.96M 2.23% 11
2016
Q4
$16M Sell
76,000
-3,500
-4% -$725K 3.06% 3
2016
Q3
$18.3M Buy
79,500
+27,500
+53% +$6.72M 2.91% 6
2016
Q2
$12M Buy
52,000
+10,000
+24% +$2.31M 2.13% 10
2016
Q1
$11.3M Sell
42,000
-13,000
-24% -$3.72M 2.23% 10
2015
Q4
$17.2M Buy
55,000
+9,000
+20% +$2.68M 2.6% 6
2015
Q3
$12.5M Buy
46,000
+4,000
+10% +$1.23M 1.99% 15
2015
Q2
$12.7M Sell
42,000
-3,300
-7% -$984K 1.53% 17
2015
Q1
$13.5M Buy
45,300
+18,300
+68% +$5.22M 2.27% 11
2014
Q4
$6.95M Buy
27,000
+7,000
+35% +$1.75M 2.01% 10
2014
Q3
$4.83M Sell
20,000
-5,000
-20% -$1.12M 1.41% 22
2014
Q2
$5.58M Buy
+25,000
New +$5.18M 1.65% 13
2014
Q1
Sell
-10,000
Closed -$1.68M 101
2013
Q4
$1.68M Buy
+10,000
New +$1.56M 0.66% 68

Other funds holding AGN

Rhenman & Partners Asset Management's AGN Position: Q2 2019 in Review

Rhenman & Partners Asset Management sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 88,600 shares — an estimated $13M sold.

Rhenman & Partners Asset Management first reported a position in AGN in Q4 2013 and held it in 21 quarters. The position peaked at $20.8M in Q2 2018. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Rhenman & Partners Asset Management reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 88,600 Allergan plc shares in Q2 2019, an estimated $13M.
  • Rhenman & Partners Asset Management first reported a position in Allergan plc in Q4 2013 and held it in 21 quarters.
  • Rhenman & Partners Asset Management's Allergan plc position peaked at $20.8M in Q2 2018.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Rhenman & Partners Asset Management's 13F filing for Q2 2019, filed 22 Jul 2019.